The reversal of an Adriamycin® induced healing impairment with chemoattractants and growth factors

Annals of Surgery

Volumn 203, Issue 2, 1986, Pages 142-147

  Lawrence, W T ^a   Gorschboth, C ^a   Norton, J A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; INSULIN; PLATELET DERIVED GROWTH FACTOR; RADIOISOTOPE; THYMIDINE H 3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; COLLAGEN; DNA; GROWTH PROMOTOR; PEPTIDE; THYMIDINE; TRANSFORMING GROWTH FACTOR;

ADVERSE DRUG REACTION; ANIMAL EXPERIMENT; BLOOD AND HEMOPOIETIC SYSTEM; DRUG THERAPY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; THERAPY; THROMBOCYTE; VISUAL SYSTEM; WOUND HEALING; ANIMAL; ARTICLE; COMPARATIVE STUDY; DRUG EFFECT; MALE; METABOLISM; RAT STRAIN;

ANIMAL; COLLAGEN; COMPARATIVE STUDY; DNA; DOXORUBICIN; EPIDERMAL GROWTH FACTOR; GROWTH SUBSTANCES; INSULIN; MALE; PEPTIDES; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, INBRED F344; THYMIDINE; TRANSFORMING GROWTH FACTORS; WOUND HEALING;

EID: 0022666942     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-198602000-00006     Document Type: Article

References (0)